After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a path forward ...

Praxis, a top biotech stock, surged Tuesday after the FDA assigned a potential approval date for its essential tremor ...

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

This small biotech could grow much larger with some good news from its pipeline.

Seaport Therapeutics, a Boston biotech led by Daphne Zohar, has filed to go public, setting up a Nasdaq debut that could funnel fresh cash into its neuropsychiatric drug pipeline. Spun out of PureTech ...

The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force ...

Biogen could see lower royalties for Ocrevus after its patent expires , but it has developed other medicines that will ...

The Spanish government is launching a venture capital fund with a goal of raising $200 million to invest in biotechnology ...

Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the human body, representing anatomy, physiology and behavior.

Questex’s Fierce Biotech today announces the winners of the 2026 Fierce Outsourcing Awards, recognizing the companies and teams driving innovation, performance, and partnership across the outsourced ...

In this edition of the biotech bi-weekly, get the latest biotech industry updates, with special focus on the upcoming AACR ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...